#COVID19 infections are still in the millions worldwide. This pandemic is far from over. COVID-19 will continue to impact our lives. #EMAPresser#pandemic
Vaccines are a central pillar of the response to the #pandemic. Nearly half a million lives among people 60 years of age and older have been saved in Europe thanks to #vaccination. #COVID19#EMAPresser
Developers of #COVID19vaccines are investigating if bivalent vaccines offer advantages to monovalent vaccines. Results from ongoing #clinicaltrials are expected in the next couple of months. #EMAPresser
#ClinicalTrials for adapted vaccines should show they are superior to the current authorised #COVID19vaccines against #omicron and other variants. EMAPresser
Our priority is to ensure that adapted #COVIDvaccines are approved by September at the latest, to be ready for the rollout of new immunisation campaigns in the 🇪🇺 in autumn. This would allow manufacturers to adjust their production lines accordingly. #EMAPresser
It’s too early to consider using a 4th dose (2nd booster) of mRNA #COVID19vaccines in general population.
People over 80 years of age could benefit from a 2nd #booster, given the higher risk of severe #COVID19 for them. #EMAPresser
We have started evaluating an application from Moderna to extend the use of #Spikevax to children from 6 months of age. This is the first application for this young age group. #EMAPresser#COVIDvaccines
Only 50% of Europeans are fully vaccinated & boosted. 15% of 🇪🇺citizens over 18 haven't received a single shot of the #COVID19vaccine.
‼️People who are not yet vaccinated or boosted should get their shot, especially if they are at a higher risk of severe disease. #EMAPresser
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Omicron & other variants: Global regulators agreed that the administration of multiple booster doses at short intervals would not be sustainable in the long term. #COVID19#EMAPresser#ICMRA
Don’t miss our tweets during the press briefing. Follow #EMAPresser.
EMA concluded that 3rd doses of #Comirnaty and #Spikevax may be given to people with severely weakened immune systems aged 12 or older, at least 28 days after their second dose. #EMAPresser
Currently approved #COVID19vaccines protect from the most acute consequence of this disease: hospitalisation and death. As many people as possible should be fully vaccinated. #EMAPresser
The evidence is becoming clearer on the need to consider additional vaccine doses for people who may poorly respond to #COVID19 vaccination, such as those with severely weakened immune systems or some elderly patients. #EMAPresser